Nevertheless, in the present study two out of five mice, which received antibody pre-incubated grafts, showed increased counts of human CD135+ events toward the end of the experiment, thus indicating a higher tumor burden and engraftment of the FLT3ITD AML cells. The gene discussed is FLT3; the disease is neoplasm.